Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

KKR-owned Healthium, Temasek-backed Romsons in race to buy 70-80% stake in BL Lifesciences

Summary by Times of India
KKR-owned Healthium Medtech and Temasek-backed Romsons Group are vying to acquire a 70-80% stake in BL Lifesciences, valued at ₹1,800-2,000 crore, indicating a significant shift in medical device market competition.

1 Articles

Times of IndiaTimes of India
Lean Right

KKR-owned Healthium, Temasek-backed Romsons in race to buy 70-80% stake in BL Lifesciences

KKR-owned Healthium Medtech and Temasek-backed Romsons Group are vying to acquire a 70-80% stake in BL Lifesciences, valued at ₹1,800-2,000 crore, indicating a significant shift in medical device market competition.

·India
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Times of India broke the news in India on Monday, October 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

KKR icon

KKR

India icon

India

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal